Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Stephen Pyke"'
Autor:
Susan Todd, Steven A. Julious, Stephen Pyke, Michael O'Kelly, James Matcham, Simon Day, Jorgen Seldrup
Publikováno v:
Pharmaceutical Statistics. 10:60-69
Since the web-based registry ClinicalTrials.gov was launched on 29 February 2000, the pharmaceutical industry has made available an increasing amount of information about the clinical trials that it sponsors. The process has been spurred on by a numb
Autor:
Susan Todd, Stephen Pyke, Jorgen Seldrup, Simon Day, James Matcham, Michael O'Kelly, Steven A. Julious
Publikováno v:
Pharmaceutical Statistics. 10:74-79
Concerns about potentially misleading reporting of pharmaceutical industry research have surfaced many times. The potential for duality (and thereby conflict) of interest is only too clear when you consider the sums of money required for the discover
Autor:
Stephen Pyke, Jorgen Seldrup, Steven A. Julious, Simon Day, James Matcham, Michael O'Kelly, Susan Todd
Publikováno v:
Pharmaceutical Statistics. 10:70-73
In this paper we set out what we consider to be a set of best practices for statisticians in the reporting of pharmaceutical industry-sponsored clinical trials. We make eight recommendations covering: author responsibilities and recognition; publicat
Autor:
Mark Cassidy, M. Jorger, Stephen Pyke, John T. S. Irvine, C. Chung, Christopher Munnings, Samir Boulfrad
Publikováno v:
Fuel Cells. 9:891-898
The limitations of the current state of the art Ni-YSZ cermet anodes with respect to Redox stability, coking and sulphur tolerance are well acknowledged. A material which mitigates all or even some of these issues would be of great importence for the
Autor:
Josef Sfeir, Jari Kiviaho, Frank Tietz, Joergen G. Larsen, Anke Hagen, Mohsine Zahid, Stephen Pyke, Olivier Bucheli, Robert Steinberger-Wilckens, B. Rietveld, L.G.J. de Haart
Publikováno v:
Steinberger-Wilckens, R, Bucheli, O, De Haart, L G J, Hagen, A, Kiviaho, J, Larsen, J, Pyke, S, Rietveld, B G, Sfeir, J, Tietz, F & Zahid, M 2009, ' Real-SOFC : A joint European effort to improve SOFC durability ', ECS Transactions, vol. 25, no. 2, pp. 43-56 . https://doi.org/10.1149/1.3205507
The Integrated Project Real-SOFC joined 26 partners from throughout Europe active in SOFC technology. The project was funded by the European Commission within the 6th Framework Programme and aimed at improving the durability of planar SOFC stacks to
Autor:
Gael Corre, Kevin D. Pointon, Andrew J. Marquis, Abul Kalam Azad, David Miller, Stephen Pyke, Richard T. Baker, Gregory J. Offer, Paul R. Shearing, John T. S. Irvine, Ahmet Selcuk, Edwardo Carvalho, Kwang-Leong Choy, R. Clague, Claire S. Adjiman, Nigel P. Brandon, Keith Scott, Alan Atkinson, Dan J. L. Brett
Publikováno v:
ECS Transactions. 25:35-42
The Supergen fuel cell programme is the UK's flagship fuel cell research consortium, funded by the Research Councils. Established just under four years ago it brings together four academic partners (Imperial College, Newcastle University, Nottingham
Publikováno v:
Journal of Power Sources. 157:745-749
The purpose of this work was to study the transient performance of solid oxide fuel cells (SOFCs) under several cycling conditions, in order to understand the degradation mechanisms. Initially, the Rolls Royce Fuel Cell IP-SOFC (Integrated Planar SOF
Publikováno v:
BMJ. 320:1368-1373
To examine the benefits of adding salmeterol compared with increasing dose of inhaled corticosteroids.Systematic review of randomised, double blind clinical trials. Independent data extraction and validation with summary data from study reports and m
Publikováno v:
Statistics in Medicine. 16:2063-2079
The statistical issues in clinical trials where clusters, communities or groups rather than individuals are randomized are often not fully appreciated. In this paper we discuss the design and analysis of trials in which pairs of clusters are randomiz
Autor:
Jørgen Jespersen, Stephen Pyke, Marie-Christine Alessi, Frits Haverkate, Ire`ne Juhan-Vague, Simon G. Thompson
Publikováno v:
Juhan-Vague, I, Pyke, S D M, Alessi, M C, Jespersen, J, Haverkate, F & Thompson, S G 1996, ' Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris ', Circulation, vol. 94, no. 9, pp. 2057-2063 . https://doi.org/10.1161/01.CIR.94.9.2057
Background Disturbances of the fibrinolytic system that lead to decreased removal of fibrin deposits may be important risk factors for coronary thrombosis. There is as yet no consensus on the prognostic value of fibrinolytic parameters, which may be